Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
Kevin P Mc Namara, Johnson George, Sharleen L O'Reilly, Shane L Jackson, Gregory M Peterson, Helen Howarth, Michael J Bailey, Gregory Duncan, Peta Trinder, Elizabeth Morabito, Jill Finch, Stephen Bunker, Edward Janus, Jon Emery, James A Dunbar
BMC HEALTH SERVICES RESEARCH | BMC | Published : 2010
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death globally. Community pharmacist intervention studies have demonstrated clinical effectiveness for improving several leading individual CVD risk factors. Primary prevention strategies increasingly emphasise the need for consideration of overall cardiovascular risk and concurrent management of multiple risk factors. It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role. METHODS/DESIGN: This study will be a longitudinal pre- and post-test pilot study with a single cohort of up to 100 patients in ten pharmacies. Patients a..View full abstract
The authors thank Professor Graham Giles of the Cancer Epidemiology Centre of The Cancer Council Victoria, for permission to use the Dietary Questionnaire for Epidemiological Studies (Version 2), Melbourne: The Cancer Council Victoria, 1996. This project, and KM's position at institution (2) is funded by the Australian Government Department of Health and Ageing as part of the Fourth Community Pharmacy Agreement through the Fourth Community Pharmacy Agreement Grants Program managed by the Pharmacy Guild of Australia. We would also like to acknowledge the contributions of the community and accredited consultant pharmacists in this study.